French drug company Sanofi said on Tuesday it is going to ditch its plans for creating its own mRNA-based COVID-19 vaccine due to the existing supply of these shots.
“Taking into account public health needs and given sufficient mRNA COVID-19 vaccines supply can be expected going forward, Sanofi has decided ...
from The Washington Times stories: Health https://ift.tt/2ZyqYao